Overall sensitivity of early cancer detection for novel blood-based assay was 82% at 95% specificity; specific cancer detection rates include colorectal (96%), lung (85%), prostate (82%) and breast (73%) Results, which demonstrate the potential of Harbinger’s biology-informed, AI-driven…